Literature DB >> 31011833

Treatment of actinic cheilitis: a systematic review.

Arthur Pias Salgueiro1, Luciano Henrique de Jesus1, Isadora Follak de Souza1, Pantelis Varvaki Rados1, Fernanda Visioli2.   

Abstract

OBJECTIVES: Actinic cheilitis is a potentially malignant disorder caused by excessive sun exposure. It affects the lower lip of individuals, mostly those with light skin color. Different treatments have been proposed for AC; however, no consensus has been reached on the best option available.
MATERIALS AND METHODS: The present study describes the results of a computer-based systematic search conducted on electronic databases to identify the best therapies.
RESULTS: A total of 29 journal articles were selected, and the results were divided according to the type of treatment employed: laser therapy, chemotherapy agents, surgical treatment, and application of anti-inflammatory agents. Clinically, photodynamic therapy showed positive results, with improvement in up to 100% of the patients; however, histopathological improvement varied greatly, from 16 to 100%. Among the chemotherapeutic agents assessed, imiquimod showed the best results: clinical improvement in 80 to 100% of the patients, and histopathological improvement in 73 to 100%. Regarding studies describing surgical approaches, the main focus was the search for the best technique, rather than the cure of AC. Finally, studies employing anti-inflammatory agents are sparse and have small samples, thus providing limited results.
CONCLUSION: The scientific evidence available on the treatment of AC is scarce and heterogeneous, photodynamic therapy, and imiquimod application are promising. CLINICAL RELEVANCE: The study of the treatments for AC in the form of a systematic review allows us to evaluate the results against the different treatments. Being a potentially malignant lesion, it is important to seek evidence about the best results found.

Entities:  

Keywords:  Actinic cheilitis; Imiquimod; Laser; Systematic review; Vermilionectomy

Year:  2019        PMID: 31011833     DOI: 10.1007/s00784-019-02895-z

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  6 in total

1.  Evaluation of effect of a vitamin-based barrier cream on the clinical severity of actinic cheilitis: A preliminary study.

Authors:  Mariana-Sudati Rodrigues; Eduardo-Oliveira Kaefer; Juliana-Tomaz Sganzerla; Humberto-Thomazi Gassen; Rubem-Beraldo Dos Santos; Sergio-Augusto-Quevedo Miguens-Jr
Journal:  J Clin Exp Dent       Date:  2020-10-01

2.  Actinic cheilitis or squamous cell carcinoma of the lip? Practical recommendations on how to avoid a trap.

Authors:  Hudson Dutra Rezende; Daniel Oliveira; Marinna Sampaio Campos; Loanda Oliveira Fukuma; Juliana de Carvalho Delgado; Sandra Lopes Mattos Dinato
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

3.  Actinic cheilitis in rural workers: prevalence and associated factors.

Authors:  Maria Helaynne Diniz Faria; Luanna Mayrany Alves Costa Silva; Rodrigo Porpino Mafra; Marquiony Marques Dos Santos; Samara Carollyne Mafra Soares; Jamile Marinho Bezerra de Oliveira Moura
Journal:  Einstein (Sao Paulo)       Date:  2022-05-27

4.  5-Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12-month follow-up study on 21 patients.

Authors:  S Radakovic; M Dangl; A Tanew
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-10       Impact factor: 6.166

Review 5.  Actinic Cheilitis - From Risk Factors to Therapy.

Authors:  Alina Vasilovici; Loredana Ungureanu; Lavinia Grigore; Elena Cojocaru; Simona Şenilă
Journal:  Front Med (Lausanne)       Date:  2022-02-15

6.  Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis.

Authors:  Mariachiara Arisi; Benedetta Galli; Edoardo Guasco Pisani; Giuseppe La Rosa; Gaetano Licata; Sara Rovaris; Cesare Tomasi; Mariateresa Rossi; Marina Venturini; Luigi Spiazzi; PierGiacomo Calzavara-Pinton
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.